Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenolization vs Conventional Surgery for Uncomplicated Sacrococcygeal Pilonidal Disease
NCT05404243Phase 4Completed
- Start
- Jan 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of phenol in pilonidal disease (2 arms). Primary endpoint: Recurrence of sacrococcygeal disease at 1 year. Started Jan 2021; status: completed.
02
Drugs
phenol
03
Conditions
pilonidal disease
Beyond the preview
Go deeper on NCT05404243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05404243.